Rating History for Infinity Pharmaceutical (INFI) by B.Riley

More Stocks Rated by B.Riley | Latest Ratings for INFI
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/15/2022 Pharm Patel Downgrade Neutral
(Buy)		 1.50
(N/A)		 0.74
(0.04)		 -94.59% Details